X
Mitsubishi Tanabe pulls ALS drug from EMA assessment
https://pharmaphorum.com/news/mitsubishi-tanabe-pulls-als-drug-from-ema-assessment/
ALS
AI-discovered candidates show promise in ALS
Candidates slow down motor neurone death in patient samples.
FDA approves first ALS treatment for two decades
FDA asked Mitsubishi to file Radicava following approval in Japan.